pimavanserin tartrate

FDA Drug Profile — NUPLAZID

pimavanserin tartrate is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including NUPLAZID. Available dosage forms: capsule, tablet, coated.

Drug details

Generic Name
pimavanserin tartrate
Brand Names
NUPLAZID
Application Number
NDA207318
Sponsor
Patheon Pharmaceuticals Inc.
NDC Codes
4
Dosage Forms
CAPSULE, TABLET, COATED
Routes
ORAL
Active Ingredients
PIMAVANSERIN TARTRATE

Indications and Usage

1 INDICATIONS AND USAGE NUPLAZID ® is indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis [ see Clinical Studies (14) ] . NUPLAZID is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.